rs2306719

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001218.5(CA12):​c.526-256A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0447 in 152,262 control chromosomes in the GnomAD database, including 198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.045 ( 198 hom., cov: 32)

Consequence

CA12
NM_001218.5 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00700

Publications

9 publications found
Variant links:
Genes affected
CA12 (HGNC:1371): (carbonic anhydrase 12) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. This gene product is a type I membrane protein that is highly expressed in normal tissues, such as kidney, colon and pancreas, and has been found to be overexpressed in 10% of clear cell renal carcinomas. Three transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2014]
CA12 Gene-Disease associations (from GenCC):
  • isolated hyperchlorhidrosis
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001218.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-63341039-T-C is Benign according to our data. Variant chr15-63341039-T-C is described in ClinVar as Benign. ClinVar VariationId is 1270897.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.061 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001218.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CA12
NM_001218.5
MANE Select
c.526-256A>G
intron
N/ANP_001209.1O43570-1
CA12
NM_206925.3
c.526-256A>G
intron
N/ANP_996808.1O43570-2
CA12
NM_001293642.2
c.346-256A>G
intron
N/ANP_001280571.1B3KUB4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CA12
ENST00000178638.8
TSL:1 MANE Select
c.526-256A>G
intron
N/AENSP00000178638.3O43570-1
CA12
ENST00000344366.7
TSL:1
c.526-256A>G
intron
N/AENSP00000343088.3O43570-2
CA12
ENST00000907869.1
c.526-256A>G
intron
N/AENSP00000577928.1

Frequencies

GnomAD3 genomes
AF:
0.0447
AC:
6803
AN:
152144
Hom.:
198
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0106
Gnomad AMI
AF:
0.0593
Gnomad AMR
AF:
0.0526
Gnomad ASJ
AF:
0.0809
Gnomad EAS
AF:
0.0133
Gnomad SAS
AF:
0.0510
Gnomad FIN
AF:
0.0497
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0626
Gnomad OTH
AF:
0.0508
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0447
AC:
6806
AN:
152262
Hom.:
198
Cov.:
32
AF XY:
0.0440
AC XY:
3274
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0106
AC:
439
AN:
41558
American (AMR)
AF:
0.0525
AC:
804
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0809
AC:
281
AN:
3472
East Asian (EAS)
AF:
0.0133
AC:
69
AN:
5178
South Asian (SAS)
AF:
0.0516
AC:
249
AN:
4822
European-Finnish (FIN)
AF:
0.0497
AC:
527
AN:
10602
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0626
AC:
4258
AN:
68014
Other (OTH)
AF:
0.0502
AC:
106
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
333
666
1000
1333
1666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0570
Hom.:
888
Bravo
AF:
0.0435
Asia WGS
AF:
0.0360
AC:
126
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.8
DANN
Benign
0.64
PhyloP100
-0.0070
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2306719;
hg19: chr15-63633238;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.